Top 10 New Entrants companies in Glycogen storage disease by Most Patent Filing In 5 Years in the world in 2022 – Discovery

Free Trial

The Glycogen storage disease top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Patent Filing In 5 Years Glycogen storage disease New Entrants in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

Ranking Year:

Region:

Ranking:

1	Sorbonne Université	Île-de-France, France		Patent: 10
2	Daiichi Sankyo Co., Ltd.	New Jersey, Japan	Clinical trial,Cardiovascular agent,Drug, ...[+2]	Patent: 8
3	Beam Therapeutics, Inc.	Massachusetts, United States	Genetic Medicine,Health care,Pharmacy and Therapeutics, ...[+2]	Patent: 6
4	National Center For Child Health & Development	Tokyo, Japan		Patent: 5
5	Dicerna Pharmaceuticals, Inc.	Massachusetts, United States	RNA,Medicine,Health care, ...[+2]	Patent: 5
6	Hiroshima University	Hiroshima, Japan	Educational institution,Test-driven development,5G, ...[+2]	Patent: 5
7	ModernaTX, Inc.	Massachusetts, United States	Messenger RNA,Medicine,Human proteins, ...[+2]	Patent: 5
8	The Institute of Myology	IF, FR		Patent: 5
9	Asklepios BioPharmaceutical, Inc.	North Carolina, United States	Biopharmaceutical,Health care,Gene delivery, ...[+2]	Patent: 4
10	Kobe Gakuin University	Hyogo, Japan	Biochemistry,Chemistry,Organic chemistry, ...[+2]	Patent: 4